Urology Doctors in West Columbia, SC Accepting Medicare

11 Urology doctors found. Showing 1 - 11

Keith Eric Brightbill Ii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 111 W Hospital Dr, West Columbia, SC 29169 Phone: 803-796-8515    Fax: 803-796-8516

Dr. Michael J Stotzer, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 139 Summerplace Drive, West Columbia, SC 29169 Phone: 803-796-9968    Fax: 803-791-0376

Dr. David H Lamb, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 101, West Columbia, SC 29169 Phone: 803-739-3660    Fax: 803-739-3663

Dr. Terence N Chapman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 101, West Columbia, SC 29169 Phone: 803-739-3660    Fax: 803-739-3663

Dr. Kelly Elizabeth Maloney, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 101, West Columbia, SC 29169 Phone: 803-739-3660

Griffin T. Morrisson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 111 W Hospital Dr, West Columbia, SC 29169 Phone: 803-796-8515    Fax: 803-796-8516

Dr. Thomas Brian Willard, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 101, West Columbia, SC 29169 Phone: 803-739-3660    Fax: 803-739-3663

Todd L Vandenberg, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 101, West Columbia, SC 29169 Phone: 803-739-3660    Fax: 803-739-3663

John C Rawl, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 222 E Medical Ln Ste 101, West Columbia, SC 29169 Phone: 803-739-3660    Fax: 803-739-3663

Philip Whitaker Kinder, M.D. Urology Medicare: Medicare Enrolled Practice Location: 222 E Medical Ln Ste 101, West Columbia, SC 29169 Phone: 803-739-3660    Fax: 803-739-3663

John G. Beasley Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 101, West Columbia, SC 29169 Phone: 803-739-3660    Fax: 803-739-3663

News Archive

Gates Foundation awards Vanderbilt University $100,000 for developing a malaria diagnostic test

Vanderbilt University announced Oct. 21 that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Associate Professor of Chemistry David Wright and Professor of Biomedical Engineering Rick Haselton, titled "Coffee Ring Stain Diagnostics for Malaria."

Eating location, food source impact daily energy intake for children

As childhood obesity rises and the American diet shifts towards increasing consumption of foods eaten or prepared outside of the home, concerns about the nutritional quality and the total consumption of such foods are also increasing.

Intercept Pharmaceuticals reports financial results for Second quarter 2013

Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, such as primary biliary cirrhosis, today reported financial results for the quarter and six months ended June 30, 2013 and announced presentations at an upcoming medical conference and upcoming investor conferences.

VARI researchers find ways to reverse resistance to sunitinib: Patients with ccRCC show positive response

Van Andel Research Institute researchers have found a way to reverse resistance to sunitinib, a treatment that is currently the first line of defense against clear cell renal cell carcinoma (ccRCC), a deadly form of kidney cancer. Most patients who show a positive response to sunitinib develop a resistance to the drug after one year of treatment.

Insmed initiates patient screening for ARIKACE phase 2 NTM lung disease trial

Insmed Incorporated, a biopharmaceutical company, today announced that it has begun screening patients for its U.S. phase 2 clinical trial, Treatment with ARIKACE to Realize Greater Efficacy Trial (TARGET-NTM), of ARIKACE (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacterial (NTM) lung disease.

Read more Medical News

› Verified 1 days ago